{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-258692","form_type":"8-K","ticker":"CRBP","cik":"0001595097","company_name":"Corbus Pharmaceuticals Holdings, Inc.","filed_at":"2025-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.864680+00:00","generated_at":"2026-05-17T01:20:33.093591+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Corbus reports preliminary Q3 cash position of $104M as of Sep 30, 2025","bullets":["Expected cash, cash equivalents, and investments of approximately $104.0 million.","Includes $27.0 million in cash and cash equivalents.","Figures are preliminary, subject to final closing procedures.","No update on sales under Jefferies ATM agreement after September 30."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-258692","json":"https://secwatch.observer/filing/0001193125-25-258692.json","markdown":"https://secwatch.observer/filing/0001193125-25-258692.md","text":"https://secwatch.observer/filing/0001193125-25-258692.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525258692/0001193125-25-258692-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525258692/crbp-20251030.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:20:33.093591+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}